Jones Financial Companies
PRCT icon

Jones Financial Companies’s Procept Biorobotics PRCT Stock Holding History

Jones Financial Companies’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
1,286
+284
+28% +$7.11K ﹤0.01% 3345
2026
Q1 		$26.4K Buy
1,002
+422
+73% +$11.9K ﹤0.01% 3181
2025
Q4 		$18.2K Sell
580
-332
-36% -$11K ﹤0.01% 2973
2025
Q3 		$33.4K Buy
912
+60
+7% +$2.74K ﹤0.01% 2548
2025
Q2 		$48.5K Buy
852
+574
+206% +$32.5K ﹤0.01% 2239
2025
Q1 		$16.7K Buy
+278
New +$19K ﹤0.01% 2500

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jones Financial Companies's PRCT Position: Q2 2026 in Review

Jones Financial Companies increased its Procept Biorobotics (PRCT) stake by 28% in Q2 2026, buying an estimated $7.11K and bringing the position to 1,286 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #3345.

Jones Financial Companies first reported a position in PRCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $48.5K in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Jones Financial Companies held 1,286 shares of Procept Biorobotics worth $29K as of Q2 2026.
  • Jones Financial Companies bought 284 Procept Biorobotics shares in Q2 2026, an estimated $7.11K.
  • Procept Biorobotics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3345 holding.
  • Jones Financial Companies first reported a position in Procept Biorobotics in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Procept Biorobotics position peaked at $48.5K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.